not tagged
Delcath Systems
['melanoma']
today at #asco22, dr. jonathan zager ( ) shares results of the focus phase 3 trial evaluating hepatic perfusion with melphalan for patients with ocular #melanoma liver metastases. check out the poster session at 4:30 p.m. cdt. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.